Inflammation in the brain's sleep center and sleep problems in aging

Preoptic/Hypothalamic Mechanisms of Sleep-Wake Regulation

NIH-funded research VA Greater Los Angeles Healthcare System · NIH-11264635

See if long-lasting inflammation in brain areas that control sleep can cause persistent sleep problems like those seen in older adults and people at risk for Alzheimer's.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Greater Los Angeles Healthcare System NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-11264635 on NIH RePORTER

What this research studies

Researchers will use mouse models that mimic aging and prolonged peripheral inflammation to track sleep patterns over weeks to months and look for lasting sleep disruption. They will trigger inflammation with agents such as LPS and compare young and aged animals to map when sleep problems appear. After monitoring sleep, they will examine the preoptic and hypothalamic brain regions for immune-cell activation and molecular changes, including ABCA1, ATE1, cholesterol buildup, F-actin, and caspase-3. The work aims to connect specific cellular and molecular changes caused by chronic inflammation to long-term sleep disturbances.

Who could benefit from this research

Good fit: People most relevant would be older adults with persistent sleep disturbances, especially those with cognitive decline or elevated risk for Alzheimer's disease.

Not a fit: Younger people with short-term insomnia or sleep problems clearly due to lifestyle factors (jet lag, shift work, acute stress) are less likely to benefit directly from these findings.

Why it matters

Potential benefit: If successful, this work could point to biological targets and strategies to prevent or treat chronic sleep problems in older adults and possibly reduce Alzheimer's-related risk.

How similar studies have performed: Prior animal studies have shown inflammation can disrupt sleep, but linking durable sleep changes to the specific molecular pathways (like ABCA1 and ATE1) and to aging-related effects is relatively new.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.